Exchange: NASDAQ·Updated 02:13 PM EDT
TRDA logo

TRDA Entrada Therapeutics Inc

$7.08
$0.09
(1.25%)
Today
Reported EarningsAug 5
Mkt Cap$279.18M
Vol208,577.00

About TRDA

Entrada Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which provides of a class of medicines that engages in intracellular targets. Its Endosomal Escape Vehicle (EEV) therapeutics are designed to enable the efficient intracellular delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. The company was founded by Dehua Pei in 2016 and is headquartered in Boston, MA.
57

Bullish Sentiment

How do you feel about TRDA?

Advertisement|Remove ads.